Back to Search
Start Over
A phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia
- Source :
- Leukemia. 37:835-842
- Publication Year :
- 2023
- Publisher :
- Springer Science and Business Media LLC, 2023.
- Subjects :
- Cancer Research
Oncology
Hematology
Subjects
Details
- ISSN :
- 14765551 and 08876924
- Volume :
- 37
- Database :
- OpenAIRE
- Journal :
- Leukemia
- Accession number :
- edsair.doi...........bcd9c6e487a35c7c8dba1553e3108c27